Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KeyWise develops and commercializes an AI-based digital biomarker platform (Skye) that passively analyzes smartphone keyboard interactions to generate objective, privacy-preserving measures of brain function and mood for mental health and cognitive assessment. It has been clinically oriented through collaborations and licensing for use in prescription digital therapeutics and remote sensing of psychiatric and cognitive conditions.[1]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KeyWise.